Jean Oak

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

Brian J. Sworder, David M. Kurtz, Stefan Alig et al. · Cancer Cell · 2022 · 119 citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, Medicine +7

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

John H. Baird, Matthew J. Frank, Juliana Craig et al. · Blood · 2020 · 80 citations · Full text

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia

Julia T. Geyer, Wayne Tam, Yen-Chun Liu et al. · Modern Pathology · 2017 · 71 citations · Full text

Hematological Malignancy, Chronic Myelomonocytic Leukemia, Medicine +9

Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase

Jean Oak, Jonathan A. Deane, Michael G. Kharas et al. · Proceedings of the National Academy of Sciences · 2006 · 64 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +19